The present study aimed to investigate the possible protective effect of Shogaol on DSS-induced colitis in BALB/c mice in comparison with 6-thioguanine (6-TG), an immunosuppressant chemotherapy, which is conventionally used for UC, based on scoring of disease activity index (DAI), histological index and EGFR expression. This evidence concerns the gene EGFR and colitis.